Data / Form D filings / Celldex Therapeutics, Inc.
Celldex Therapeutics, Inc.: Form D filings
Celldex Therapeutics, Inc., a biotechnology company in Hampton, NJ, filed 2 Form D notices with the SEC between 2014 and 2016. The latest, on November 29, 2016, reports $62.5 million sold of a $62.5 million offering to 29 investors.
Find out what Celldex Therapeutics, Inc. does, who founded it and who invested, beyond what the filing says. $10 of credit on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 53 FRONTAGE ROAD, SUITE 220, Hampton, NJ, 08827
- Phone
- (908) 200-7500
- Industry
- Biotechnology
- Entity type
- Corporation
- Incorporated in
- Delaware
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 744218
The full lists. Form D filings in New Jersey: 714 rows, $35.70, or the new rows each week for $19 a month. Form D filings in Biotechnology: 1,568 rows, $78.40, or the new rows each week for $19 a month. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (company, CIK, year incorporated, street, city, state and 5 more), which open on your screen as soon as the payment clears and come by email. For agents and scripts: every list with its row count and price is at https://specstream.ai/data/lists.json.
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Nov 29, 2016 | New notice | $62,500,000 | $62,500,000 | $0 | 29 | Nov 29, 2016 | sec.gov |
| Oct 24, 2014 | New notice | $2,000,000 | $2,000,000 | $0 | 1 | Oct 15, 2014 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Herbert J. Conrad | Director | |
| Anthony S. Marucci | Executive Officer, Director | |
| Karen O. Shoos | Director | |
| Richard H. van den Broek | Director | |
| Larry J. Ellberger | Director | |
| Avery W. Catlin | Executive Officer | |
| George O. Elston | Director | |
| Harry H. Penner, Jr. | Director |
Other biotechnology companies in New Jersey that filed recently
- Ensho Therapeutics, Inc. $7.3 million · Oct 15, 2026
- Xenon Ophthalmics Inc $3.3 million · Oct 6, 2026
- LISATA THERAPEUTICS, INC. $351.9 million · Oct 2, 2026
Every Form D from the week of Nov 28, 2016 · All recent filings in New Jersey · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what Celldex Therapeutics, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.
$10 of credit on sign-up, no card.